Mandibular prognathia AND surgery (LeFortI or BSSO or LeFortI AND BSSO), including avohilmo

K11_MN_PROGN_AND_SURGRT_INCLAVO

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Primary healthcare outpatient: ICD-10 K07.11

1 out of 7 registries used, show all original rules.

223

4. Check minimum number of events

None

223

5. Include endpoints

394

6. Filter based on genotype QC (FinnGen only)

394

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

First used in FinnGen datafreeze
DF12

Case counts by codes

FinnGen case counts by registry codes:

Not enough data for upset plot.

Full data table

Summary Statistics

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 8708 3947 4747
Only index persons 7257 3299 3958
Unadjusted period prevalence (%)
Whole population 0.12 0.11 0.13
Only index persons 0.14 0.12 0.15
Median age at first event (years)
Whole population 12.20 12.16 12.17
Only index persons 13.34 13.35 13.33

-FinnGen-

Key figures

All Female Male
Number of individuals 394 242 152
Unadjusted period prevalence (%) 0.08 0.08 0.07
Median age at first event (years) 26.48 26.82 25.96

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS (R11)

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
331
Matched controls
3308
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
K07.11
ICD-10 Finland
Retrognathism (mandibular)(maxillary)
+∞
323.0
331
*
EEC05
NOMESCO Finland
Le Fort I osteotomy
2018.9
140.1
126
*
K07.14
ICD-10 Finland
Retrognaty, maxillary
138.0
125.2
128
15
SBB10
NOMESCO Finland
Teeth copy
17.1
112.6
224
360
K07.25
ICD-10 Finland
Anomalies of dental arch relationship
27.5
108.5
157
105
SJD00
NOMESCO Finland
Removal or reattacment of arrow in fixed orthodontisk device
18.0
94.9
164
171
EDC10
NOMESCO Finland
Sagittal osteotomy of ramus of mandible
110.3
89.9
95
12
SJD10
NOMESCO Finland
Attachment of arrow to fixed orthodontisk device
15.7
84.9
155
176
EB1MA
NOMESCO Finland
Cephalometry with X-ray
15.7
81.0
146
158
SJD20
NOMESCO Finland
Attachment of modifiable arrow of fixed orthodontisk device
17.3
78.7
134
125
SJC10
NOMESCO Finland
Orthodontic bandage in one tooth
15.8
77.1
137
141
SJC50
NOMESCO Finland
Removal of orthodontisk device with at least 7 brackets
14.7
73.0
134
146
SBB00
NOMESCO Finland
Fotograf of mouth and teeth
14.1
71.9
135
154
SJD40
NOMESCO Finland
Fixation of ready made palatinal or lingual arrow
12.0
65.3
133
175
SJD30
NOMESCO Finland
Demanding attachment of arrow to fixed orthodontisk device
17.5
64.6
107
88
SJX10
NOMESCO Finland
Short check-up visit for orthodontisk therapy
9.6
62.3
149
260
SJB00
NOMESCO Finland
Fitting of loose orthodontic device with user information
10.9
60.0
128
180
K07.10
ICD-10 Finland
Asymmetry of jaw
82.0
49.8
55
8
SAA04
NOMESCO Finland
Special inverstigation of mouth
7.9
46.5
121
224
SXC05
NOMESCO Finland
Other oral or dental procedure
7.3
44.6
124
251
SJC03
NOMESCO Finland
Positioning and fixed attachment of brackets, extensive
10.6
44.2
92
116
K07.24
ICD-10 Finland
Open bite
20.6
42.3
64
38
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
11.8
40.3
78
84
K07.1
ICD-10 Finland
Anomalies of jaw-cranial base relationship
151.1
38.6
40
*
SJC00
NOMESCO Finland
Bracket with fixed attachment
110.2
36.6
39
*
SJC01
NOMESCO Finland
Positioning and fixed attachment of single bracket (Bracket with fixed attachment)
8.1
36.5
89
143
K07.13
ICD-10 Finland
Retrognaty, mandibular
13.4
35.1
63
57
SJC40
NOMESCO Finland
Removal of orthodontisk device with at most 6 brackets
7.5
34.2
88
152
SJX20
NOMESCO Finland
Check-up visit for orthodontisk therapy
8.0
34.1
83
132
SAA03
NOMESCO Finland
Extended examination of mouth
4.5
33.4
251
1363
SHB00
NOMESCO Finland
Prepation and fitting of bite rail to mouth
6.1
31.2
96
209
SJA04
NOMESCO Finland
Very demanding plan for orthodontic care
318.5
29.3
29
*
K07.18
ICD-10 Finland
Another anomaly in the relationship between jaw and skull base
158.4
28.1
29
*
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
3.7
27.7
218
1137
EFB40
NOMESCO Finland
Removal of internal or external fixation device from facial bones
48.7
26.0
31
7
WZC05
NOMESCO Finland
Specialty-specific consultation based on referral by dentist or doctor
5.8
25.9
80
172
SJX11
NOMESCO Finland
Therapeutic intervention or check-up related to orthodontic treatment, restricted
5.3
25.8
88
212
K07.01
ICD-10 Finland
Hyperplasia, hypoplasia mandibular
76.1
25.2
28
*
SJX21
NOMESCO Finland
Therapeutic intervention or check-up related to orthodontic treatment
5.6
25.1
80
178
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
3.4
24.8
179
844
SJB60
NOMESCO Finland
External device grinding and adaptation
6.3
24.4
69
132
SJA03
NOMESCO Finland
Demanding plan for orthodontic care
73.2
24.2
27
*
SJC02
NOMESCO Finland
Positioning and fixed attachment of brackets
7.0
23.5
61
103
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
7.0
21.8
56
93
K07.21
ICD-10 Finland
Anomalies of dental arch relationship
26.3
21.2
29
12
K07.60
ICD-10 Finland
Snapping jaw
6.5
20.2
55
99
K07.03
ICD-10 Finland
Micrognatia (hypoplasia) of the upper jaw
55.8
18.2
21
*
SJA01
NOMESCO Finland
Estimation of need for orthodontic care
44.7
17.5
21
5
SHA02
NOMESCO Finland
Correction of physiology of bite - basic therapy visit
5.0
17.0
58
136
SHA03
NOMESCO Finland
Correction of physiology of bite - demanding therapy visit
7.9
16.1
37
52
K07.12
ICD-10 Finland
Prognathism (mandibular)(maxillary)
63.2
15.9
18
*
K07.19
ICD-10 Finland
Anomalies in the relationship between jaw and skull base UNS
89.4
15.7
17
*
SAC03
NOMESCO Finland
Separate planning of oral and dental treatment, very demanding
11.7
15.3
28
26
K07.30
ICD-10 Finland
Spacing, abnormal of tooth or teeth
4.0
15.3
65
189
EBB10
NOMESCO Finland
Insertion of dental implant
15.1
14.8
24
17
SAC02
NOMESCO Finland
Separate planning of oral and dental treatment, demanding
5.1
13.7
44
96
SJA02
NOMESCO Finland
Plan for orthodontic care
52.2
12.9
15
*
ZXE20
NOMESCO Finland
More than three and less than five hours
3.3
11.5
62
214
K00.00
ICD-10 Finland
Hypodontia
6.5
11.3
29
48
SXC03
NOMESCO Finland
Other oral or dental procedure
12.5
11.0
19
16
Z3229
NOMESCO Finland
Other healthcare associate professional
4.0
10.8
44
122
EB1BI
NOMESCO Finland
Cone beam imaging of teeth and jaws (1–2 quarters)
12.6
10.5
18
15
EB1WA
NOMESCO Finland
NA
16.7
10.5
16
10
SJX00
NOMESCO Finland
Reparation of orthodontiskt device by dentist
8.9
10.2
21
25
ZXX02
NOMESCO Finland
Extent of procedure, 2 units
9.1
9.4
19
22
SJB10
NOMESCO Finland
Fitting of loose orthodontic device with user information, demanding
4.7
9.0
30
69
SAC01
NOMESCO Finland
Separate planning of oral and dental treatment, standard
3.4
8.9
43
138
SAA02
NOMESCO Finland
Basic examination of mouth
2.4
8.9
277
2258
SJD50
NOMESCO Finland
Production and attachment of palatinal or lingual arrow
7.3
8.7
20
29
AA3AI
NOMESCO Finland
Cone beam CT of facial bones
12.0
8.7
15
13
K07.69
ICD-10 Finland
Dislocation of the jaw joint UNS
8.9
8.4
17
20
ZXA10
NOMESCO Finland
Bilateral
2.6
8.0
62
270
K07.4
ICD-10 Finland
Malocclusion, unspecified
6.9
8.0
19
29
DM1AD
NOMESCO Finland
CT of paranasal sinuses and face area
6.0
7.7
20
35
OIKK
NOMESCO Finland
NA
2.8
7.6
50
197
EB1AI
NOMESCO Finland
Cone beam imaging of teeth and jaws (one quarter)
7.4
7.6
17
24
SHA01
NOMESCO Finland
Correction of physiology of bite - simple therapy visit
2.8
7.6
50
198
ZXE30
NOMESCO Finland
More than five and less than seven hours
4.1
7.3
27
70
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
4.3
7.2
25
61
K01.0
ICD-10 Finland
Embedded teeth
4.9
7.2
22
47
EBA10
NOMESCO Finland
Surgical removal of tooth
2.3
7.0
68
332
WX408
NOMESCO Finland
General anesthesy, balanced
2.0
7.0
102
595
SPA00
NOMESCO Finland
Changing form of teeth in prepation for prothetic work
5.0
7.0
21
44
SXB00
NOMESCO Finland
Removeal of sutres from oral mucosa
3.3
6.9
33
106
SJF01
NOMESCO Finland
Assessment of need for orthodontic treatment
2.7
6.6
45
181
ECB40
NOMESCO Finland
Surgical treatment of fracture of alveolus
12.6
6.6
11
9
SJE90
NOMESCO Finland
Finishing face of orthodontick therapy
7.6
6.5
14
19
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
3.9
6.4
25
68
EEC02
NOMESCO Finland
Rapid expansion of maxilla
+∞
6.3
6
*
K01.17
ICD-10 Finland
Retained molar with obstruction in the lower jaw
4.1
6.1
22
56
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
2.3
6.0
57
273

LabWAS

OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
25
137
1.88
2.19
2.0
2.9
ng/l
56.1
99.7
1.21
20
124
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
71
514
1.47
2.13
2.1
2.0
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
172
1449
1.33
2.08
3.0
3.4
estimate
0.0
0.0
0.00
24
286
(3021601) Nitrite [Presence] in Urine by Test strip
170
1435
1.32
2.01
4.4
4.7
estimate
0.0
0.0
0.00
25
296
(3035350) Ketones [Presence] in Urine by Test strip
170
1436
1.32
1.99
3.0
3.3
estimate
0.0
0.0
0.00
24
286
(3041806) Other cells [#/volume] in Blood by Manual count
7
23
3.08
1.80
1.6
1.7
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
322
3007
1.39
1.74
8.8
11.8
mmol/l
3.9
3.9
0.44
313
2908
(3002385) Erythrocyte distribution width [Ratio]
311
2889
1.36
1.73
11.4
13.6
%
13.2
13.3
0.46
301
2842
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
58
424
1.43
1.67
2.1
1.9
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
321
3003
1.37
1.66
8.8
11.8
mmol/l
139.6
139.7
0.11
315
2914
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
7
25
2.83
1.65
6.3
5.6
ug/l
0.7
1.6
—
7
25
(40765089) Chromosome analysis panel - Blood by G-banded
8
32
2.53
1.60
1.0
1.0
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
57
421
1.41
1.56
1.7
1.6
pmol/l
432.8
18011216.4
0.50
47
372
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
23
138
1.71
1.55
1.1
1.2
u/ml
0.4
2.4
1.44
12
71
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
261
2385
1.28
1.51
5.0
4.3
mmol/mol
38.0
38.2
0.17
247
2262
(3019897) Erythrocyte distribution width [Ratio] by Automated count
9
37
2.47
1.49
1.9
1.6
%
13.0
13.3
—
9
37
(3010726) Horse dander IgE Ab [Units/volume] in Serum
20
118
1.73
1.44
1.2
1.1
u/ml
8.8
2.7
—
5
24
(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection
6
22
2.75
1.44
1.8
2.1
—
1224630.0
—
0
5
(3044889) 12 lead EKG panel
200
1782
1.25
1.39
2.7
2.9
—
—
—
0
0
(3022621) pH of Urine by Test strip
24
151
1.63
1.38
2.5
2.2
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
146
1257
1.26
1.37
3.6
8.4
mmol/l
1.2
1.2
2.71
124
1105
(3041096) Erythrocytes [Presence] in Urine by Automated
100
822
1.29
1.37
2.9
3.0
—
—
—
0
0
(3045462) Protein/Creatinine [Ratio] in Urine
0
37
0.00
1.35
0.0
7.9
—
98.6
—
0
31
(3008401) Mugwort IgE Ab [Units/volume] in Serum
20
121
1.69
1.33
1.0
1.2
u/ml
4.2
0.6
0.44
13
77
(3013826) Glucose [Moles/volume] in Serum or Plasma
180
1592
1.24
1.32
3.2
5.4
mmol/l
6.3
6.4
0.14
163
1433
(40761535) Cells panel - Urine sediment
9
176
0.50
1.32
1.9
3.1
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
265
2448
1.25
1.29
4.2
3.8
pmol/l
14.4
14.5
0.45
243
2254
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
303
2846
1.28
1.26
4.6
4.3
mu/l
1.8
2.2
0.51
278
2667
(3019150) Specific gravity of Urine by Refractometry
85
691
1.29
1.26
3.0
3.1
kg/l
1.0
1.0
1.26
12
96
(3003888) Timothy IgE Ab [Units/volume] in Serum
20
124
1.65
1.23
1.1
1.2
u/ml
13.9
9.1
0.39
14
88
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
7
144
0.48
1.23
1.0
1.2
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
223
2030
1.23
1.21
3.7
4.1
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
127
1094
1.24
1.16
3.0
3.3
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
123
1056
1.24
1.16
2.6
2.3
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
22
143
1.57
1.14
1.8
1.6
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
303
2859
1.26
1.13
3.9
3.7
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
280
2622
1.23
1.11
3.6
3.3
mmol/l
5.6
5.7
0.50
263
2428
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
8
41
1.97
1.09
1.3
1.3
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
8
41
1.97
1.09
1.3
1.1
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
82
677
1.27
1.08
1.5
1.6
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
16
252
0.62
1.07
4.6
5.2
—
—
—
0
0
(4035726)
11
189
0.57
1.03
1.6
1.4
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
5
106
0.46
1.02
1.0
1.1
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
5
109
0.45
1.02
1.0
1.1
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
5
110
0.45
1.01
1.0
1.1
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
5
110
0.45
1.01
1.0
1.8
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
23
156
1.50
1.01
1.4
1.2
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
21
306
0.67
1.00
4.4
11.2
mmol/l
24.6
25.0
0.47
21
306
(3013707) Erythrocyte sedimentation rate by Westergren method
234
2165
1.20
0.99
3.4
3.9
mm/h
7.8
8.9
1.32
224
2007
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
30
0.00
0.97
0.0
1.4
—
—
—
0
0
(3000492) Spirometry study
38
287
1.36
0.96
1.5
1.4
—
—
—
0
0
(3026250) Tacrolimus [Mass/volume] in Blood
0
32
0.00
0.95
0.0
31.1
—
6.7
—
0
26
(3020630) Protein [Mass/volume] in Serum or Plasma
8
144
0.55
0.95
2.1
2.5
g/l
64.5
66.6
—
8
134
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
6
27
2.24
0.94
1.0
1.1
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
43
333
1.33
0.93
1.4
1.5
nmol/l
1216.5
1144.5
0.24
36
264
(3015736) pH of Urine
131
1156
1.20
0.93
3.2
3.0
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
44
342
1.32
0.93
2.0
1.9
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
39
299
1.34
0.90
1.2
1.6
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
18
264
0.67
0.90
1.2
1.2
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
41
318
1.32
0.88
1.3
1.3
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
98
847
1.21
0.86
6.3
5.5
inr
1.1
1.1
0.04
41
271
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
20
284
0.69
0.85
3.7
6.7
mmol/l
1.6
1.6
—
10
198
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
0
24
0.00
0.79
0.0
1.0
—
121.7
—
0
16
(3035933) Granulocytes/100 leukocytes in Blood
6
34
1.78
0.76
1.3
1.2
—
—
—
0
0
(3016244) Insulin [Units/volume] in Serum or Plasma
12
75
1.62
0.75
3.8
2.9
mu/l
78.2
18.7
0.46
12
70
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
8
132
0.60
0.75
1.5
1.6
g/l
1.1
1.2
—
8
124
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
6
106
0.56
0.73
1.0
1.8
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
5
26
1.93
0.71
1.0
1.1
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
5
26
1.93
0.71
1.2
1.3
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
96
844
1.18
0.70
2.5
2.3
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
17
238
0.70
0.69
1.5
1.4
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
146
1329
1.16
0.69
3.8
4.1
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
10
61
1.66
0.69
1.3
1.0
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
5
27
1.86
0.68
1.0
1.5
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
25
189
1.34
0.66
1.0
1.2
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
8
130
0.61
0.65
1.5
1.6
g/l
0.2
0.2
—
8
124
(4027681)
5
29
1.73
0.64
1.0
1.2
—
—
—
0
0
(4010399)
24
182
1.34
0.63
1.8
1.4
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
336
3262
1.20
0.63
7.2
8.7
u/l
26.7
26.7
0.00
326
3163
(3009542) Hematocrit [Volume Fraction] of Blood
328
3179
1.19
0.61
10.7
12.0
%
40.5
40.4
0.07
263
2644
(44813793)
5
30
1.67
0.61
1.0
1.0
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
331
3211
1.19
0.61
9.3
10.7
mg/l
22.4
20.8
0.39
254
2346
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
8
51
1.58
0.60
1.4
5.1
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
0
20
0.00
0.60
0.0
3.2
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
0
20
0.00
0.60
0.0
2.5
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
0
20
0.00
0.60
0.0
5.1
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
0
20
0.00
0.60
0.0
1.1
—
216.5
—
0
20
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
0
21
0.00
0.60
0.0
11.6
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
0
21
0.00
0.60
0.0
1.2
—
—
—
0
0
(3002256) Pathology report gross observation
36
292
1.26
0.59
1.3
1.2
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
64
552
1.19
0.59
1.6
1.5
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
7
111
0.62
0.59
1.6
2.6
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
7
115
0.60
0.58
1.4
1.3
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
0
23
0.00
0.58
0.0
1.7
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
0
23
0.00
0.58
0.0
1.7
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
0
23
0.00
0.58
0.0
1.7
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
284
2727
1.15
0.58
3.8
3.8
mmol/l
2.7
2.8
0.66
270
2555
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
80
705
1.17
0.58
2.4
2.2
mg/l
2.5
2.8
0.50
73
611
(3022313) Gas panel - Capillary blood
18
240
0.74
0.57
3.8
7.0
—
—
—
0
0
(3018133) Calcium [Moles/volume] in Urine
6
36
1.68
0.57
1.8
3.2
mmol/l
4.2
2.3
—
6
36
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
5
86
0.58
0.57
1.2
2.2
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
5
88
0.56
0.56
1.0
1.5
—
60.0
—
0
9
(3034770) Mitochondria Ab [Titer] in Serum
5
89
0.56
0.56
1.0
1.5
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
5
89
0.56
0.56
1.0
1.1
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
47
396
1.21
0.56
1.1
1.2
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
6
37
1.63
0.56
2.7
3.7
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
88
785
1.16
0.55
2.5
2.1
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
143
1319
1.13
0.55
4.2
6.8
umol/l
13.2
11.1
0.64
137
1240
(3042936) Bacteria identified in Isolate by Culture
28
348
0.79
0.54
1.8
2.1
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
6
38
1.59
0.54
1.2
1.4
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
221
2094
1.13
0.54
4.7
6.6
u/l
77.4
85.4
1.64
213
1973
(3006315) Basophils [#/volume] in Blood
153
1644
0.89
0.54
5.0
6.8
e9/l
0.0
0.0
0.20
132
1422
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
11
74
1.50
0.54
2.9
11.1
%
1.5
1.6
0.17
11
67
(3001604) Monocytes [#/volume] in Blood
153
1643
0.89
0.53
5.0
6.8
e9/l
0.5
0.5
0.72
132
1421
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
282
2714
1.14
0.53
3.5
3.6
mmol/l
4.6
4.7
0.57
268
2566
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
86
768
1.15
0.53
2.3
2.8
ng/l
57.5
29.7
0.31
39
396
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
32
260
1.25
0.53
2.5
2.5
u/l
27.3
216.0
0.52
27
221
(40760892) CBC W Ordered Manual Differential panel - Blood
65
740
0.85
0.53
4.0
4.9
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
42
497
0.83
0.53
1.5
1.7
%
1.3
1.4
0.54
37
460
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
6
40
1.51
0.52
2.0
1.3
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
11
75
1.48
0.51
2.9
10.9
%
0.9
0.9
0.02
11
69
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
248
2586
0.89
0.51
7.9
8.8
ml/min/173m2
95.9
95.3
0.16
189
1971
(3022145) Colonoscopy Study observation
34
280
1.23
0.51
1.3
1.3
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
12
84
1.44
0.50
1.2
1.1
u/ml
2.4
6.6
—
7
30
(36304419) Bacteria [Presence] in Urine
69
777
0.86
0.49
3.0
3.5
—
—
—
0
0
(4062490)
7
45
1.57
0.49
1.1
1.2
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
58
506
1.17
0.48
1.3
1.4
nmol/l
20.6
20.0
0.11
51
438
(3000570) Elastase.pancreatic [Mass/mass] in Stool
11
76
1.46
0.48
1.5
1.3
ug/g
211.2
311.8
—
6
37
(3039000) Anion gap in Blood
7
46
1.53
0.48
3.0
15.1
mmol/l
11.0
11.1
—
7
40
(3018572) Chloride [Moles/volume] in Blood
7
46
1.53
0.48
3.0
15.1
mmol/l
106.1
105.3
—
7
40
(3024891) Influenza virus A+B Ag [Presence] in Specimen
17
128
1.34
0.48
1.0
1.2
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
20
254
0.78
0.47
2.2
2.6
ug/l
0.6
0.7
—
8
141
(1761482) Bacteria [#/volume] in Urine by Culture
7
49
1.44
0.46
6.4
3.3
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
279
2694
1.12
0.46
3.5
3.5
mmol/l
1.5
1.5
0.19
265
2533
(1002224) Polysomnography panel
9
129
0.69
0.44
1.1
1.1
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
14
104
1.36
0.43
5.2
2.7
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
73
809
0.88
0.42
1.7
1.7
—
—
—
0
0
(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection
0
15
0.00
0.41
0.0
7.8
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
0
16
0.00
0.41
0.0
1.6
—
1.1
—
0
16
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
0
16
0.00
0.41
0.0
5.6
—
16.3
—
0
16
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
0
17
0.00
0.40
0.0
1.5
—
1.9
—
0
17
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
0
17
0.00
0.40
0.0
1.0
—
1369.1
—
0
17
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
0
17
0.00
0.40
0.0
1.6
—
15.9
—
0
8
(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection
0
17
0.00
0.40
0.0
6.8
—
—
—
0
0
(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection
0
17
0.00
0.40
0.0
6.7
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
57
505
1.15
0.40
1.2
1.2
u/ml
13.3
7.7
0.20
23
194
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
25
205
1.23
0.40
2.2
2.7
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
0
18
0.00
0.40
0.0
1.4
—
0.6
—
0
7
(3024932) HLA-DR beta [Type]
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
0
18
0.00
0.40
0.0
6.2
—
—
—
0
0
(3024471) HLA-A [Type]
0
18
0.00
0.40
0.0
1.0
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
0
19
0.00
0.39
0.0
3.7
—
66.6
—
0
19
(3042733) HLA Ab [Presence] in Serum
0
19
0.00
0.39
0.0
2.5
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
5
36
1.39
0.38
2.6
1.7
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
11
147
0.74
0.38
1.2
1.4
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
142
1507
0.91
0.38
7.8
8.9
e9/l
0.0
0.0
0.53
112
1192
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
8
114
0.70
0.37
1.5
6.1
%
0.9
1.5
—
8
114
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
9
70
1.29
0.37
2.2
1.5
—
—
—
0
0
(3013512) EKG study
52
583
0.88
0.36
3.1
3.1
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
94
867
1.11
0.36
1.8
2.5
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
9
71
1.27
0.36
6.8
1.6
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
5
76
0.65
0.36
4.8
10.5
—
404.2
—
0
17
(3020682) Albumin/Creatinine [Ratio] in Urine
65
587
1.13
0.36
4.0
4.2
mg/mmol
2.5
12.9
3.56
40
393
(3012516) Albumin [Mass/volume] in Urine
63
568
1.13
0.35
3.1
3.5
mg/l
1289.3
203.2
0.40
39
387
(3000991) Gas panel - Venous blood
26
308
0.83
0.35
3.2
12.2
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
10
134
0.74
0.35
1.1
1.3
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
113
1055
1.10
0.35
1.6
1.5
u/ml
1.2
2.5
0.98
23
240
(3013139) Helicobacter pylori Ag [Presence] in Stool
22
182
1.22
0.34
1.5
1.2
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
17
208
0.81
0.32
1.1
1.2
—
27.5
—
0
10
(4094501)
7
52
1.35
0.31
1.1
1.2
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
78
844
0.91
0.31
3.1
3.6
e6/l
37.2
116.3
0.50
60
640
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
16
196
0.81
0.30
1.4
1.8
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
163
1705
0.92
0.30
4.8
6.7
e9/l
2.0
2.1
0.41
144
1508
(3052851) Hemolysis interference index of Serum or Plasma
11
84
1.32
0.30
1.3
3.1
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
21
249
0.83
0.30
3.1
4.6
u/l
254.5
246.2
0.07
21
239
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
87
934
0.91
0.29
2.9
3.7
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
93
868
1.09
0.29
1.6
1.7
pmol/l
102.2
98.5
0.32
51
434
(3025130) Human papilloma virus identified in Specimen
7
57
1.23
0.29
1.6
1.9
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
158
1509
1.08
0.29
3.1
2.9
ug/l
66.7
78.0
0.69
148
1411
(3006504) Eosinophils/100 leukocytes in Blood
149
1561
0.93
0.28
5.4
6.9
%
3.2
2.9
0.58
141
1479
(3019069) Monocytes/100 leukocytes in Blood
150
1571
0.93
0.28
5.6
7.2
%
8.3
8.3
0.05
143
1496
(3037522) Nuclear Ab [Titer] in Serum
38
426
0.88
0.28
1.5
1.5
titre
426.7
500.7
—
6
81
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
14
172
0.81
0.28
1.3
1.4
miu/ml
198.7
299.4
—
7
86
(3035637) Corticotropin [Mass/volume] in Plasma
8
64
1.26
0.27
1.1
1.7
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
8
67
1.20
0.26
1.0
1.1
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
5
74
0.67
0.26
1.8
1.3
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
17
142
1.21
0.25
1.9
6.8
g/l
0.2
0.3
—
9
90
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
15
180
0.83
0.24
1.3
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
15
180
0.83
0.24
1.3
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
15
180
0.83
0.24
1.3
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
15
180
0.83
0.24
1.3
1.4
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
76
709
1.09
0.24
1.7
1.7
mmol/l
1.5
1.3
0.77
65
639
(3024561) Albumin [Mass/volume] in Serum or Plasma
106
1005
1.07
0.23
4.2
6.0
g/l
37.9
37.4
0.51
94
956
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
12
97
1.24
0.23
1.3
1.6
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
40
440
0.90
0.22
2.1
3.5
ng/l
416.8
646.2
0.67
30
366
(3018095) Leukocytes [#/volume] in Urine
95
1003
0.93
0.22
3.4
4.2
e6/l
25.6
48.7
0.92
65
674
(3018418) pH of Serum or Plasma
65
697
0.92
0.22
2.8
3.7
ph
7.4
7.4
0.24
11
123
(3013115) Eosinophils [#/volume] in Blood
163
1689
0.94
0.22
5.0
7.3
e9/l
0.2
0.2
0.61
146
1495
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
47
431
1.10
0.22
2.6
3.3
ng/l
73.2
716.3
1.66
32
265
(42870560) Thyrotropin [Units/volume] in Cord blood
0
11
0.00
0.21
0.0
1.0
—
18.4
—
0
5
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
0
11
0.00
0.21
0.0
1.8
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
0
11
0.00
0.21
0.0
1.8
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
11
0.00
0.21
0.0
1.1
—
9.4
—
0
11
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
0
11
0.00
0.21
0.0
1.8
—
—
—
0
0
(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
2.7
—
28.8
—
0
5
(3002619) Bacteria identified in Specimen by Culture
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3041082) Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence
0
10
0.00
0.21
0.0
1.9
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
0
10
0.00
0.21
0.0
1.2
—
541.3
—
0
10
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
10
0.00
0.21
0.0
1.7
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
264
2585
1.06
0.21
3.1
3.3
mmol/l
1.2
1.2
0.25
249
2431
(3001964) Herpes simplex virus Ag [Presence] in Specimen
0
12
0.00
0.21
0.0
3.0
—
—
—
0
0
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
0
12
0.00
0.21
0.0
1.0
—
30.1
—
0
7
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
2.2
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
1.4
—
—
—
0
0
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
0
12
0.00
0.21
0.0
1.0
—
236.9
—
0
7
(3032868) Hemoglobin electrophoresis panel in Blood
0
12
0.00
0.21
0.0
1.6
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
0
12
0.00
0.21
0.0
2.7
—
—
—
0
0
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
0
12
0.00
0.21
0.0
1.0
—
561.1
—
0
7
(3002621) Streptococcal DNAse B [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
1.0
—
24.3
—
0
7
(3017732) Neutrophils [#/volume] in Blood
22
192
1.15
0.21
1.2
2.7
e9/l
4.3
4.0
0.24
22
176
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
0
13
0.00
0.21
0.0
1.3
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
0
13
0.00
0.21
0.0
6.8
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
7.5
—
—
—
0
0
(3013336) Amino acids [Identifier] in Serum or Plasma
0
13
0.00
0.21
0.0
2.3
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
0
14
0.00
0.20
0.0
1.7
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
0
14
0.00
0.20
0.0
1.7
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
1.3
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
0
14
0.00
0.20
0.0
1.7
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
0
14
0.00
0.20
0.0
1.7
—
—
—
0
0
(3010015) Selenium [Moles/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
2.6
—
1.2
—
0
14
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
5.2
—
280.0
—
0
6
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
12
144
0.83
0.20
1.8
5.8
%
98.3
93.3
0.51
12
139
(3003458) Phosphate [Moles/volume] in Serum or Plasma
40
436
0.91
0.19
2.2
9.0
mmol/l
1.1
1.2
0.13
34
411
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
117
1220
0.94
0.19
2.5
2.8
nmol/l
72.2
71.7
0.06
109
1138
(3003694) ABO and Rh group [Type] in Blood
99
1037
0.94
0.19
1.7
1.6
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
89
935
0.94
0.18
1.8
1.5
g/l
1.7
2.0
0.56
54
537
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
10
121
0.82
0.18
2.2
6.0
%
121.2
168.7
—
10
121
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
7
60
1.17
0.18
1.4
1.2
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
38
349
1.10
0.18
1.8
1.7
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
12
142
0.84
0.17
1.3
1.4
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
12
142
0.84
0.17
1.3
1.4
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
21
186
1.14
0.17
2.8
3.4
e9/l
84.5
70.9
0.25
15
131
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
7
63
1.11
0.17
1.1
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
7
63
1.11
0.17
1.1
1.3
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
25
277
0.90
0.16
2.4
2.4
u/l
21511.4
4499.9
—
8
105
(3029634) Reagin Ab [Titer] in Serum by VDRL
8
71
1.13
0.16
1.4
1.8
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
8
71
1.13
0.16
2.3
1.4
u/l
10.5
18.6
—
8
61
(3014148) Varicella zoster virus Ab [Titer] in Serum
8
72
1.11
0.16
1.0
1.2
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
6
77
0.78
0.15
2.7
1.9
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
6
78
0.77
0.15
1.0
1.2
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
6
80
0.75
0.15
2.7
1.8
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
147
1512
0.96
0.14
5.5
7.1
%
0.7
0.7
0.36
138
1436
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
7
90
0.77
0.14
1.0
2.7
mg/l
437.9
446.8
—
7
85
(3026493) Urate [Moles/volume] in Serum or Plasma
63
598
1.06
0.14
2.0
3.1
umol/l
321.9
6281.1
2.42
58
526
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
18
160
1.13
0.14
1.2
1.6
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
369
3666
1.10
0.14
13.6
15.7
e9/l
259.4
259.7
0.03
361
3562
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
33
356
0.92
0.14
2.7
2.5
mmol/l
2.4
2.4
0.51
28
304
(3008152) Bicarbonate [Moles/volume] in Arterial blood
14
122
1.15
0.14
2.7
10.7
mmol/l
25.1
24.6
0.22
14
111
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
8
98
0.81
0.14
1.0
1.3
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
42
448
0.93
0.13
3.4
3.3
e6/l
3.3
3.2
0.01
22
251
(3034274) Bile acid [Moles/volume] in Serum --fasting
8
100
0.80
0.13
2.8
4.1
umol/l
3.7
10.8
—
8
75
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
49
462
1.07
0.13
3.1
3.2
e6/l
0.6
0.9
0.46
27
264
(3026008) Bacteria identified in Urine by Culture
73
763
0.95
0.13
3.1
2.4
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
30
277
1.09
0.13
1.9
1.8
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
108
1116
0.96
0.13
4.9
6.7
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
18
200
0.90
0.12
1.5
1.5
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
32
344
0.92
0.12
1.5
1.5
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
56
532
1.06
0.12
1.4
1.6
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
11
127
0.86
0.12
4.7
14.3
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
37
346
1.08
0.12
3.7
3.5
%
25.7
22.2
0.47
12
133
(3002030) Lymphocytes/100 leukocytes in Blood
160
1637
0.96
0.12
5.3
6.9
%
32.9
31.3
1.19
151
1562
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
12
137
0.87
0.12
1.0
1.7
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
70
671
1.05
0.12
2.5
3.2
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
41
387
1.07
0.11
1.3
1.3
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
21
228
0.92
0.10
4.6
5.3
%
0.0
0.8
—
6
70
(40768804) Tissue Pathology biopsy report
105
1021
1.04
0.10
2.0
1.8
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
54
564
0.95
0.10
4.0
4.3
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
5
44
1.14
0.10
2.6
1.6
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
339
3366
1.05
0.10
9.2
9.2
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
87
843
1.04
0.10
3.4
3.7
mmol/l
8.3
8.6
0.20
77
747
(44790049)
5
46
1.09
0.09
1.0
1.8
—
—
—
0
0
(44790047)
5
46
1.09
0.09
1.0
1.8
—
—
—
0
0
(44790048)
5
46
1.09
0.09
1.0
1.8
—
—
—
0
0
(44806118)
5
46
1.09
0.09
1.0
1.8
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
13
145
0.89
0.09
1.5
1.4
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
369
3672
1.08
0.09
13.6
15.7
e12/l
4.6
4.6
1.19
359
3561
(3030467) Casts [#/volume] in Urine by Automated count
74
765
0.96
0.09
3.2
3.6
e6/l
0.5
0.3
0.21
57
569
(3028300) Cannabinoids [Presence] in Urine
31
329
0.94
0.09
3.0
1.8
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
26
243
1.07
0.09
1.2
1.3
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
15
165
0.91
0.09
5.1
2.1
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
6
54
1.11
0.09
2.5
1.7
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
29
308
0.94
0.08
3.1
1.9
—
—
—
0
0
(3008898) HLA-B27 [Presence]
16
175
0.91
0.08
1.0
1.1
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
28
263
1.07
0.08
3.7
3.8
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
6
57
1.05
0.08
1.0
1.1
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
369
3673
1.07
0.08
13.6
15.7
e9/l
6.7
6.6
0.07
358
3558
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
10
113
0.88
0.08
1.6
1.9
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
5
61
0.82
0.08
2.4
2.7
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
78
757
1.04
0.08
2.8
3.5
estimate
0.0
0.0
0.50
24
289
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
5
64
0.78
0.08
1.0
2.0
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
13
117
1.11
0.08
2.2
2.2
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
118
1155
1.03
0.08
2.2
1.8
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
31
327
0.94
0.08
3.2
1.8
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
31
327
0.94
0.08
3.2
1.8
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
6
70
0.85
0.07
1.3
1.4
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
30
284
1.06
0.07
1.9
1.8
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
22
235
0.93
0.07
3.3
11.0
mmol/l
1.6
0.7
0.66
16
186
(3045414) Leukocytes [Presence] in Urine
12
108
1.11
0.07
2.0
1.6
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
31
326
0.95
0.07
3.0
1.8
—
—
—
0
0
(4034850)
9
84
1.07
0.07
7.9
7.2
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
19
177
1.08
0.06
1.7
1.5
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
13
142
0.91
0.06
2.1
2.3
u/ml
14.8
32.3
1.77
13
135
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
33
315
1.05
0.06
1.9
2.9
%
23.5
24.6
0.18
26
280
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
14
152
0.92
0.06
1.9
1.6
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
29
276
1.05
0.06
1.1
1.0
—
—
—
0
0
(3019060) Gas panel - Arterial blood
13
119
1.10
0.06
2.3
8.2
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
66
643
1.03
0.05
2.1
1.7
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
36
346
1.04
0.05
1.3
1.5
—
—
—
0
0
(3019225) pH of Specimen
21
198
1.06
0.05
1.4
3.9
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
32
333
0.96
0.05
1.4
1.5
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
18
191
0.94
0.04
2.3
11.3
g/l
126.7
123.8
0.29
18
182
(3021440) Promyelocytes/100 leukocytes in Blood
20
211
0.95
0.04
4.8
5.5
%
0.0
0.1
—
5
61
(1001926) Buprenorphine [Presence] in Urine by Screen method
25
261
0.95
0.04
3.5
1.9
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
159
1606
0.98
0.04
5.1
6.7
%
52.8
54.2
0.88
152
1531
(40758558) Short blood count panel - Blood
82
834
0.98
0.04
4.2
7.7
—
—
—
0
0
(3026782) Osmolality of Urine
55
538
1.03
0.03
2.4
3.0
mosm/kgh2o
556.5
581.7
0.32
48
463
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
13
122
1.07
0.02
1.4
1.6
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
117
1159
1.01
0.02
3.4
8.3
mmol/l
1.2
1.2
1.86
104
1075
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
27
278
0.97
0.02
1.3
1.3
iu/ml
101.0
144.9
0.35
11
113
(3013650) Neutrophils [#/volume] in Blood by Automated count
186
1850
1.01
0.02
6.3
9.5
e9/l
3.7
3.8
0.32
164
1596
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
16
167
0.96
0.01
1.5
1.6
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
23
237
0.97
0.01
4.4
2.3
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
10
97
1.03
0.00
1.2
1.5
—
0.0
—
0
15
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
13
127
1.02
0.00
1.5
1.4
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
13
127
1.02
0.00
1.3
1.5
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
27
267
1.01
0.00
1.3
1.6
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
39
387
1.01
0.00
1.8
1.9
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
55
547
1.01
0.00
3.2
2.6
ug/g
196.1
93.6
1.13
47
425
(3015377) Calcium [Moles/volume] in Serum or Plasma
82
825
0.99
0.00
2.2
3.0
mmol/l
2.4
2.4
0.91
75
739
(46235355) HIV 1 and 2 tests - Meaningful Use set
102
1016
1.01
0.00
2.4
2.0
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
13
126
1.03
0.00
1.9
1.9
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
20
196
1.02
0.00
1.8
1.9
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
51
514
0.99
0.00
1.2
1.3
iu/ml
17.1
27.1
0.74
21
145
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
61
614
0.99
0.00
1.5
2.5
mg/l
0.6
1.1
1.67
45
448
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
7
73
0.96
0.00
4.4
2.7
u/ml
959.4
1883.1
—
7
63
(3033882) Carnitine [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
3.0
—
33.0
—
0
7
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
9
92
0.98
0.00
2.0
1.8
—
—
—
0
0
(3006598) pH of Arterial cord blood
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum
0
9
0.00
0.00
0.0
1.2
—
11.9
—
0
9
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
0
8
0.00
0.00
0.0
2.3
—
—
—
0
0
(3008860) Bordetella pertussis IgM Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
5
51
0.98
0.00
2.4
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
7
0.00
0.00
0.0
1.0
—
30.7
—
0
7
(3013637) Mi-2 Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
8
86
0.93
0.00
1.0
1.1
—
—
—
0
0
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
0
6
0.00
0.00
0.0
1.0
—
6.8
—
0
6
(3038177) Helicobacter pylori Ab [Presence] in Serum
5
57
0.88
0.00
1.2
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
8
86
0.93
0.00
1.0
1.1
—
—
—
0
0
(3001556) Androgen free Index in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3017115) Methotrexate [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
17.4
—
0.5
—
0
8
(3000722) Carnitine free (C0) [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
3.0
—
24.6
—
0
7
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(3036048) Francisella tularensis Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(46235168) Fasting glucose [Moles/volume] in Blood
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
8
86
0.93
0.00
2.8
1.4
—
—
—
0
0
(3032352) Blasts [#/volume] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
10.5
—
—
—
0
0
(3004959) Base excess in Arterial cord blood by calculation
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3032641) Amino acids panel - Urine
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
8
80
1.00
0.00
2.3
1.3
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
9
96
0.94
0.00
1.2
1.2
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
7
74
0.94
0.00
1.0
3.1
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
5
54
0.92
0.00
1.0
2.3
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
5
49
1.02
0.00
2.6
1.7
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
67
670
1.00
0.00
1.7
2.4
—
—
—
0
0
(3006576) Bicarbonate [Moles/volume] in Blood
0
6
0.00
0.00
0.0
9.3
—
25.6
—
0
6
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3049233) Organic acids panel - Urine
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
0
8
0.00
0.00
0.0
1.8
—
—
—
0
0
(3001186) Copper [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.7
—
18.8
—
0
9
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3011436) Histone Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
5
57
0.88
0.00
1.2
1.3
—
—
—
0
0
(3022670) pH of Venous cord blood
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3041672) Baker's yeast Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(40768443) Skin Pathology biopsy report
9
93
0.97
0.00
1.0
1.2
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3005593) Pancreatic islet cell Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
11
110
1.00
0.00
1.3
2.1
u/l
38.7
38.7
0.01
11
104
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
12
120
1.00
0.00
1.8
1.4
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
7
78
0.90
0.00
1.0
1.1
—
—
—
0
0
(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0

Mortality – FinRegistry

Association

Association between endpoint K11_MN_PROGN_AND_SURGRT_INCLAVO and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have K11_MN_PROGN_AND_SURGRT_INCLAVO.

N-year risk Females Males
1 No data No data
5 No data No data
10 No data No data
15 No data No data
20 No data No data

Relationships between endpoints

Index endpoint: K11_MN_PROGN_AND_SURGRT_INCLAVO – Mandibular prognathia AND surgery (LeFortI or BSSO or LeFortI AND BSSO), including avohilmo

GWS hits: 1

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data